assesses risk factors beyond the standard metrics, helping physicians prioritize patients who may require more urgent screening. "Our goal is to ensure that every patient receives top-quality care, ...

Brittany Pieniazek knew she had a chance of developing breast cancer. The Dyer resident’s mother and aunt had both been ...

Currently, in the US, the lifetime risk of developing the disease is around one in 24. Research is still ongoing into exactly ...

This belief persists is because red wine has been associated with cardiovascular benefits in some research. The "French ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

Establishing growing body of preclinical data evaluating the DNase-based oncology platform across a number of high-value ...

With more lung cancer cases being detected via both incidental findings and early screenings, robotic-assisted surgery can make for an all around better experience for patients. Charles Simmons, a ...

Former Full House star Dave Coulier has been diagnosed with stage 3 non-Hodgkin lymphoma, a form of cancer that affects the lymphatic system, the actor announced on the Today show Wednesday. The ...

In the UK, 46 people per day die from colorectal cancer (CRC), with it being the third ... offers potential in terms of the ...

" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...

Decoy product candidates represent an antigen-agnostic technology that have produced single-agent activity against metastatic pancreatic and orthotopic colorectal carcinomas ... forward-looking ...

"Recently, we reported initial clinical data from our STARLING trial which showcased durable anti-tumor activity in a heavily pre-treated late-line microsatellite stable colorectal cancer ...